Clinical trial
Nelfinavir Mesylate in Treating Patients With Recurrent, Metastatic, or…
NCT00233948 · City of Hope Medical Center, Other · Terminated
Key facts
| NCT number | NCT00233948 |
|---|---|
| Title | Nelfinavir Mesylate in Treating Patients With Recurrent, Metastatic, or Unresectable Liposarcoma |
| Official title | A Phase I/II Study of Nelfinavir in Liposarcoma |
| Lead sponsor | City of Hope Medical Center, Other |
| Status | Terminated |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Adult Liposarcoma, Recurrent Adult Soft Tissue Sarcoma, Stage III Adult Soft Tissue Sarcoma, Stage IV Adult Soft Tissue Sarcoma |
| Intervention type | Drug, Genetic, Other, Procedure |
| Interventions | nelfinavir mesylate, biopsy, laboratory biomarker analysis, pharmacological study, gene expression analysis, western blotting, reverse transcriptase-polymerase chain reaction, immunoenzyme technique |
| Enrollment | 29 |
| Start date | Mar 1, 2006 |
| Primary completion | Jul 1, 2013 |
| First posted | Oct 6, 2005 |
| Last update posted | Apr 1, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: